Skip to main content

Cancer Moonshot℠ – Funding Opportunities

The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.

 

Open Funding Opportunity Announcements (FOAs)
BRP Recommendation Title Announcement Number Receipt Date
Therapeutic Target Identification to Overcome Resistance Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) RFA-CA-19-049 Multiple
Network for Direct Patient Engagement Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) RFA-CA-19-045 Multiple
Drug Resistance Network Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported Drug Resistance and Sensitivity Network (DRSN) NOT-CA-20-014 06/02/2020
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ – Funding Opportunities was originally published by the National Cancer Institute.”